These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 7925321

  • 1. Protein kinase inhibitors.
    Hidaka H, Kobayashi R.
    Essays Biochem; 1994; 28():73-97. PubMed ID: 7925321
    [No Abstract] [Full Text] [Related]

  • 2. KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
    Tokumitsu H, Chijiwa T, Hagiwara M, Mizutani A, Terasawa M, Hidaka H.
    J Biol Chem; 1990 Mar 15; 265(8):4315-20. PubMed ID: 2155222
    [Abstract] [Full Text] [Related]

  • 3. Search for the functional substrate proteins of protein kinases and their selective inhibitors.
    Hidaka H, Watanabe M, Tokumitsu H.
    Adv Second Messenger Phosphoprotein Res; 1990 Mar 15; 24():485-90. PubMed ID: 2169823
    [No Abstract] [Full Text] [Related]

  • 4. Presence and possible involvement of Ca/calmodulin-dependent protein kinases in insulin release from the rat pancreatic beta cell.
    Niki I, Okazaki K, Saitoh M, Niki A, Niki H, Tamagawa T, Iguchi A, Hidaka H.
    Biochem Biophys Res Commun; 1993 Feb 26; 191(1):255-61. PubMed ID: 8383489
    [Abstract] [Full Text] [Related]

  • 5. Properties and use of H-series compounds as protein kinase inhibitors.
    Hidaka H, Watanabe M, Kobayashi R.
    Methods Enzymol; 1991 Feb 26; 201():328-39. PubMed ID: 1658551
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of insulin secretion by KN-62, a specific inhibitor of the multifunctional Ca2+/calmodulin-dependent protein kinase II.
    Wenham RM, Landt M, Walters SM, Hidaka H, Easom RA.
    Biochem Biophys Res Commun; 1992 Nov 30; 189(1):128-33. PubMed ID: 1333187
    [Abstract] [Full Text] [Related]

  • 7. Peptide inhibitors of PKC and CaMK block induction but not expression of long-term potentiation.
    Tsien RW, Schulman H, Malinow R.
    Adv Second Messenger Phosphoprotein Res; 1990 Nov 30; 24():101-7. PubMed ID: 2169790
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of protein kinase inhibitors in an assay system containing multiple protein kinase activities.
    Li PM, Fukazawa H, Mizuno S, Uehara Y.
    Anticancer Res; 1993 Nov 30; 13(6A):1957-64. PubMed ID: 8297101
    [Abstract] [Full Text] [Related]

  • 9. [Calmodulin dependent regulation of smooth muscle contraction].
    Hidaka H, Ishikawa T, Tokumitsu H.
    Nihon Heikatsukin Gakkai Zasshi; 1990 Oct 30; 26(5):234-5. PubMed ID: 2103931
    [No Abstract] [Full Text] [Related]

  • 10. [Molecular pharmacology on protein kinase C].
    Hidaka H, Naka M.
    Tanpakushitsu Kakusan Koso; 1986 May 30; 31(6):534-48. PubMed ID: 3529244
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of protein kinase activities in rabbit ciliary processes: identification and characterization using exogenous substrates.
    Yoshimura N, Mittag TW, Podos SM.
    Exp Eye Res; 1987 Jul 30; 45(1):45-56. PubMed ID: 3477466
    [Abstract] [Full Text] [Related]

  • 12. [Inhibitor of calmodulin and calmodulin dependent enzyme].
    Hidaka H, Naito Y.
    Tanpakushitsu Kakusan Koso; 1998 Sep 30; 43(12 Suppl):1732-8. PubMed ID: 9788175
    [No Abstract] [Full Text] [Related]

  • 13. Activation of multiple protein kinases induced by cross-linking of Fc gamma RII in human neutrophils.
    Liang L, Huang CK.
    J Leukoc Biol; 1995 Feb 30; 57(2):326-31. PubMed ID: 7531749
    [Abstract] [Full Text] [Related]

  • 14. A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death.
    Hajimohammadreza I, Probert AW, Coughenour LL, Borosky SA, Marcoux FW, Boxer PA, Wang KK.
    J Neurosci; 1995 May 30; 15(5 Pt 2):4093-101. PubMed ID: 7538570
    [Abstract] [Full Text] [Related]

  • 15. Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
    Hagiwara M, Inagaki M, Watanabe M, Ito M, Onoda K, Tanaka T, Hidaka H.
    Mol Pharmacol; 1987 Jul 30; 32(1):7-12. PubMed ID: 2955213
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of angiotensin II- and potassium-mediated aldosterone secretion by KN-62 suggests involvement of Ca(2+)-calmodulin dependent protein kinase II in aldosterone secretion.
    Ganguly A, Li L, Haxton M.
    Biochem Biophys Res Commun; 1995 Apr 26; 209(3):916-20. PubMed ID: 7733984
    [Abstract] [Full Text] [Related]

  • 17. Calmodulin-dependent protein kinases mediate calcium-induced slow motility of mammalian outer hair cells.
    Puschner B, Schacht J.
    Hear Res; 1997 Aug 26; 110(1-2):251-8. PubMed ID: 9282907
    [Abstract] [Full Text] [Related]

  • 18. Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity.
    Engh RA, Girod A, Kinzel V, Huber R, Bossemeyer D.
    J Biol Chem; 1996 Oct 18; 271(42):26157-64. PubMed ID: 8824261
    [Abstract] [Full Text] [Related]

  • 19. Basal phosphorylation of mu opioid receptor is agonist modulated and Ca2+-dependent.
    Wang Z, Arden J, Sadée W.
    FEBS Lett; 1996 May 27; 387(1):53-7. PubMed ID: 8654566
    [Abstract] [Full Text] [Related]

  • 20. Decreased phosphorylation of four 20-kDa proteins precedes staurosporine-induced disruption of the actin/myosin cytoskeleton in rat astrocytes.
    Mobley PL, Hedberg K, Bonin L, Chen B, Griffith OH.
    Exp Cell Res; 1994 Sep 27; 214(1):55-66. PubMed ID: 8082748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.